| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause.
|
Neurology
|
2007
|
4.28
|
|
2
|
Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease.
|
Brain
|
2007
|
3.82
|
|
3
|
The role of radiotracer imaging in Parkinson disease.
|
Neurology
|
2005
|
3.02
|
|
4
|
Superficial siderosis.
|
Neurology
|
2006
|
2.98
|
|
5
|
Pathologic heterogeneity in clinically diagnosed corticobasal degeneration.
|
Neurology
|
1999
|
2.81
|
|
6
|
Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment.
|
Mov Disord
|
1994
|
2.77
|
|
7
|
Aversive properties of the negative stimulus in a successive discrimination.
|
J Exp Anal Behav
|
1969
|
2.75
|
|
8
|
Cognitive impairment after ECT in patients with Parkinson's disease and psychiatric illness.
|
Am J Psychiatry
|
1992
|
2.68
|
|
9
|
REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century.
|
Neurology
|
2010
|
2.50
|
|
10
|
Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study.
|
Neurology
|
2000
|
2.31
|
|
11
|
Increased risk of parkinsonism in women who underwent oophorectomy before menopause.
|
Neurology
|
2007
|
2.22
|
|
12
|
Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study.
|
Mov Disord
|
2000
|
2.20
|
|
13
|
Selective peripheral denervation for torticollis: preliminary results.
|
Mayo Clin Proc
|
1991
|
2.12
|
|
14
|
Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study.
|
Neurology
|
2009
|
2.09
|
|
15
|
Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism.
|
Neurology
|
2003
|
1.97
|
|
16
|
Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990.
|
Arch Neurol
|
1993
|
1.91
|
|
17
|
Pseudotumor cerebri.
|
Ann Intern Med
|
1982
|
1.78
|
|
18
|
Neurologic manifestations in welders with pallidal MRI T1 hyperintensity.
|
Neurology
|
2005
|
1.75
|
|
19
|
Imaging correlates of pathology in corticobasal syndrome.
|
Neurology
|
2010
|
1.71
|
|
20
|
Medical records documentation of constipation preceding Parkinson disease: A case-control study.
|
Neurology
|
2009
|
1.64
|
|
21
|
Stereotactic ventrolateralis thalamotomy for medically refractory tremor in post-levodopa era Parkinson's disease patients.
|
J Neurosurg
|
1991
|
1.57
|
|
22
|
Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project.
|
Neurology
|
1993
|
1.57
|
|
23
|
Head trauma preceding PD: a case-control study.
|
Neurology
|
2003
|
1.54
|
|
24
|
Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.
|
J Neurol Neurosurg Psychiatry
|
1995
|
1.47
|
|
25
|
Autonomic involvement in extrapyramidal and cerebellar disorders.
|
Clin Auton Res
|
1991
|
1.44
|
|
26
|
Education and occupations preceding Parkinson disease: a population-based case-control study.
|
Neurology
|
2005
|
1.43
|
|
27
|
Validity of family history data on PD: evidence for a family information bias.
|
Neurology
|
2003
|
1.41
|
|
28
|
Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study.
|
Mov Disord
|
2001
|
1.35
|
|
29
|
Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.
|
Sleep Med
|
2013
|
1.31
|
|
30
|
Idiopathic intracranial hypertension.
|
Mayo Clin Proc
|
1994
|
1.28
|
|
31
|
Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals.
|
Neurology
|
2006
|
1.24
|
|
32
|
Hemimasticatory spasm: clinical and electrophysiologic observations.
|
Neurology
|
1992
|
1.21
|
|
33
|
Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease.
|
Sleep Med
|
2006
|
1.10
|
|
34
|
Multicenter study of cabergoline, a long-acting dopamine receptor agonist, in Parkinson's disease patients with fluctuating responses to levodopa/carbidopa.
|
Neurology
|
1993
|
1.07
|
|
35
|
Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study.
|
Neurology
|
2006
|
1.04
|
|
36
|
Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity.
|
Neurology
|
2006
|
1.01
|
|
37
|
Effectiveness of ECT in patients with parkinsonism.
|
J Neuropsychiatry Clin Neurosci
|
1998
|
0.99
|
|
38
|
Movement disorders as sequelae of central pontine myelinolysis: report of three cases.
|
Mov Disord
|
1992
|
0.98
|
|
39
|
Focal shoulder-elevation dystonia.
|
Mov Disord
|
2000
|
0.95
|
|
40
|
Clinical presentation and pharmacological therapy in corticobasal degeneration.
|
Arch Neurol
|
1998
|
0.95
|
|
41
|
Utility of an EMG mapping study in treating cervical dystonia.
|
Muscle Nerve
|
2000
|
0.94
|
|
42
|
Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies.
|
Parkinsonism Relat Disord
|
2011
|
0.94
|
|
43
|
Constrictive pericarditis and pleuropulmonary disease linked to ergot dopamine agonist therapy (cabergoline) for Parkinson's disease.
|
Mayo Clin Proc
|
1999
|
0.94
|
|
44
|
Amantadine treatment is an independent predictor of improved survival in Parkinson's disease.
|
Neurology
|
1996
|
0.93
|
|
45
|
Hereditary late-onset chorea without significant dementia: genetic evidence for substantial phenotypic variation in Huntington's disease.
|
Neurology
|
1995
|
0.93
|
|
46
|
Neuropsychological profiles of manganese neurotoxicity.
|
Eur J Neurol
|
2006
|
0.92
|
|
47
|
Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology.
|
Eur J Neurol
|
2013
|
0.92
|
|
48
|
Drug-induced parkinsonism as a risk factor for Parkinson's disease: a historical cohort study in Olmsted County, Minnesota.
|
Mayo Clin Proc
|
1998
|
0.91
|
|
49
|
Surgical therapy for tremor in multiple sclerosis: an evaluation of outcome measures.
|
Neurology
|
2001
|
0.88
|
|
50
|
The role of autonomic testing in the differentiation of Parkinson's disease from multiple system atrophy.
|
J Neurol Sci
|
2012
|
0.87
|
|
51
|
PHNO [(+)-4-propyl-9-hydroxynaphthoxazine]: a new and effective anti-Parkinson's disease agent.
|
Neurology
|
1988
|
0.87
|
|
52
|
Novelty seeking and introversion do not predict the long-term risk of Parkinson disease.
|
Neurology
|
2010
|
0.84
|
|
53
|
Decreased catecholamines in the adrenal medulla of patients with parkinsonism.
|
N Engl J Med
|
1988
|
0.84
|
|
54
|
Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls.
|
Neurology
|
2001
|
0.84
|
|
55
|
Overeating and obesity from damage to a noradrenergic system in the brain.
|
Science
|
1973
|
0.83
|
|
56
|
Computer-assisted stereotactic ventralis lateralis thalamotomy with microelectrode recording control in patients with Parkinson's disease.
|
Mayo Clin Proc
|
1987
|
0.83
|
|
57
|
Parkinson's disease complicated by anxiety.
|
Mayo Clin Proc
|
1987
|
0.83
|
|
58
|
Total shoulder arthroplasty in patients with Parkinson's disease.
|
J Shoulder Elbow Surg
|
1997
|
0.82
|
|
59
|
Autonomic failure in Guamanian neurodegenerative disease.
|
Neurology
|
1997
|
0.81
|
|
60
|
A limited role for DJ1 in Parkinson disease susceptibility.
|
Neurology
|
2004
|
0.80
|
|
61
|
Decreased adrenal medullary catecholamines in adrenal transplanted parkinsonian patients compared to nephrectomy patients.
|
Exp Neurol
|
1989
|
0.80
|
|
62
|
Decreased catecholamine content in parkinsonian adrenal medullae.
|
Exp Neurol
|
1989
|
0.80
|
|
63
|
Clinical and imaging characterization of progressive spastic dysarthria.
|
Eur J Neurol
|
2013
|
0.79
|
|
64
|
Progressive supranuclear palsy phenotype secondary to CADASIL.
|
Parkinsonism Relat Disord
|
2003
|
0.78
|
|
65
|
Deprenyl in the treatment of symptom fluctuations in advanced Parkinson's disease.
|
Clin Neuropharmacol
|
1988
|
0.78
|
|
66
|
A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease.
|
Mov Disord
|
1998
|
0.78
|
|
67
|
The symptomatic and functional outcome of stereotactic thalamotomy for medically intractable essential tremor.
|
J Neurosurg
|
1992
|
0.78
|
|
68
|
Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's disease.
|
Neurology
|
1996
|
0.78
|
|
69
|
Hupothalamic hyperphagia: dissociation from hyperphagia following destruction of noradrenergic neurons.
|
Science
|
1975
|
0.78
|
|
70
|
Surgical therapy for multiple sclerosis tremor: a 12-year follow-up study.
|
Eur J Neurol
|
2012
|
0.77
|
|
71
|
Food intake and amphetamine anorexia after selective forebrain norepinephrine loss.
|
Brain Res
|
1974
|
0.77
|
|
72
|
Feeding response to regulatory challenges after 6-hydroxydopamine injection into the brain noradrenergic pathways.
|
Physiol Behav
|
1976
|
0.76
|
|
73
|
Adrenal medullary autograft transplantation into the striatum of patients with Parkinson's disease.
|
Mayo Clin Proc
|
1989
|
0.76
|
|
74
|
Intranasal apomorphine rescue therapy for parkinsonian "off" periods.
|
Clin Neuropharmacol
|
1996
|
0.76
|
|
75
|
Body weight and regulatory deficits following unilateral nigrostriatal lesions.
|
Brain Res
|
1977
|
0.76
|
|
76
|
Neurodegenerative diseases of Guam: analysis of TAU.
|
Neurology
|
1999
|
0.76
|
|
77
|
Diminished amphetamine anorexia and enhanced fenfluramine anorexia after midbrain 6-hydroxydopamine.
|
Psychopharmacology (Berl)
|
1984
|
0.76
|
|
78
|
Selective detection and identification of phosphorylated proteins by simultaneous ligand-exchange fluorescence detection and mass spectrometry.
|
J Chromatogr A
|
2006
|
0.76
|
|
79
|
Comparative Review of Dopamine Receptor Agonists in Parkinson's Disease.
|
CNS Drugs
|
1996
|
0.76
|
|
80
|
Violent recurrent ballism associated with infections in two children with static encephalopathy.
|
Mov Disord
|
2000
|
0.75
|
|
81
|
Decreased levels of [Met]enkephalin, neuropeptide Y, substance P, and vasoactive intestinal peptide in parkinsonian adrenal medulla.
|
Exp Neurol
|
1991
|
0.75
|
|
82
|
Does levodopa therapy delay death in Parkinson's disease?
|
Mov Disord
|
1996
|
0.75
|
|
83
|
Measurement of lumbar CSF levels of met-enkephalin, encrypted met-enkephalin, and neuropeptide Y in normal patients and in patients with Parkinson's disease before and after autologous transplantation of adrenal medulla into the caudate nucleus.
|
J Lab Clin Med
|
1990
|
0.75
|
|
84
|
Selegiline and mortality in subjects with Parkinson's disease: a longitudinal community study.
|
Neurology
|
2001
|
0.75
|
|
85
|
Carbidopa/levodopa for smoking cessation: a pilot study with negative results.
|
Nicotine Tob Res
|
2000
|
0.75
|
|
86
|
Effect of MK-458 (HPMC) in Parkinson's disease previously untreated with dopaminergic drugs. A double-blind, placebo-controlled multicenter study.
|
Clin Neuropharmacol
|
1991
|
0.75
|
|
87
|
Posttraumatic cervical dystonia.
|
Mayo Clin Proc
|
1993
|
0.75
|
|
88
|
Catecholamines in CSF, plasma, and tissue after autologous transplantation of adrenal medulla to the brain in patients with Parkinson's disease.
|
J Lab Clin Med
|
1989
|
0.75
|
|
89
|
Superficial siderosis and csf hypovolemia: the defect (dural) in the link.
|
Neurology
|
2007
|
0.75
|
|
90
|
Treatment of putative immune-mediated and idiopathic cervical dystonia with intravenous methylprednisolone.
|
Neurology
|
1997
|
0.75
|